Fast Five Quiz: Long-Acting Injectable Antipsychotics

Ravinder N. Bhalla, MD


August 19, 2021

APA guidelines suggest that LAI antipsychotics be offered to patients with schizophrenia if they prefer such treatment or if they have a history of poor or uncertain adherence, within the context of a person-centered treatment plan that includes evidence-based nonpharmacologic and pharmacologic treatments for schizophrenia.

Learn more about the treatment of schizophrenia.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.